Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 6:10 PM ET


Company Overview of Onconova Therapeutics, Inc.

Key Executives for Onconova Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Ramesh Kumar Ph.D.15 RelationshipsCo-Founder, Chief Executive Officer, President and Director59
E. Premkumar Reddy Ph.D.15 RelationshipsFounder, Lead Scientific Advisor and Director71
Ajay Bansal No RelationshipsChief Financial Officer and Secretary53
Thomas J. McKearn M.D., Ph.D.23 RelationshipsPresident of Research and Development66
Steven M. Fruchtman M.D.No RelationshipsChief Medical Officer and Senior Vice President of Research & Development64
View More Key Executives

Onconova Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Michael B. Hoffman J.D. 94 RelationshipsRiverstone Holdings LLC65
Ramesh Kumar Ph.D. 15 RelationshipsOnconova Therapeutics, Inc.59
E. Premkumar Reddy Ph.D. 15 RelationshipsOnconova Therapeutics, Inc.71
Alan R. Williamson Ph.D. 60 RelationshipsOnconova Therapeutics, Inc.78
Viren Mehta Pharma.D. 15 RelationshipsMehta Partners LLC65
View All Board Members

Onconova Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Anne M. VanLent63 Relationships3 Executives
Compensation Committee J.D.Michael B. Hoffman94 Relationships2 Executives
Nominating Committee Pharma.D.Viren Mehta15 Relationships2 Executives
Corporate Governance Committee Pharma.D.Viren Mehta15 Relationships2 Executives
Advisory Board Ph.D.Alan R. Williamson60 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$713.4K
Compensation as of Fiscal Year 2014
Onconova Therapeutics, Inc. CEO Compensation
Industry Average


Composition of Suominen's Nomination Board
September 02, 2015 6:30 AM ET
Michael C Feenan Joins SCA as Vice President of Personal Care Business in North America
August 26, 2015 10:30 AM ET
Alissa Sears to Join Aunt Fannie's, Inc.'s Board of Advisors
August 24, 2015 1:22 PM ET
The National Detergent Co. SAOG Announces Board Changes
August 20, 2015 10:16 AM ET
Kimberly-Clark Corporation Announces Resignation of Linda Johnson Rice from the Board of Directors
August 18, 2015 8:42 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Onconova Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at